These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1243 related articles for article (PubMed ID: 7691728)

  • 1. Morphological, phenotypic and functional characteristics of a pure population of CD56+ CD16- CD3- large granular lymphocytes generated from human duodenal mucosa.
    Pang G; Buret A; Batey RT; Chen QY; Couch L; Cripps A; Clancy R
    Immunology; 1993 Jul; 79(3):498-505. PubMed ID: 7691728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro responsiveness to interleukins and theophylline of CD16+, CD56- natural killer cells in a patient with chronic granular lymphocyte disorder.
    Bayle C; Vitté-Mony I; Lang P; Pico J; Hercend T; Bertoglio J
    Leukemia; 1992 May; 6(5):470-6. PubMed ID: 1375700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel CD56- lymphokine-activated killer cell precursor in cancer patients receiving recombinant interleukin 2.
    McKenzie RS; Simms PE; Helfrich BA; Fisher RI; Ellis TM
    Cancer Res; 1992 Nov; 52(22):6318-22. PubMed ID: 1384959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
    Gaddy J; Broxmeyer HE
    Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic and functional analysis of human CD3- decidual leucocyte clones.
    Christmas SE; Bulmer JN; Meager A; Johnson PM
    Immunology; 1990 Oct; 71(2):182-9. PubMed ID: 2146213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia.
    Robertson MJ; Cochran KJ; Cameron C; Le JM; Tantravahi R; Ritz J
    Exp Hematol; 1996 Feb; 24(3):406-15. PubMed ID: 8599969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel large granular lymphocyte-like cell isolated from IL-2-supplemented murine intestinal lamina propria lymphocyte cultures with potent inhibitory action on lymphocyte proliferation.
    Hörnqvist E; Enerbäck L; Chen XJ; Lycke N
    Cell Immunol; 1993 Apr; 148(1):71-90. PubMed ID: 8495492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CD56 adhesion molecule is the major determinant for detecting non-major histocompatibility complex-restricted cytotoxic mononuclear cells from the intestinal lamina propria.
    Van Tol EA; Verspaget HW; Peña AS; Kraemer CV; Lamers CB
    Eur J Immunol; 1992 Jan; 22(1):23-9. PubMed ID: 1370415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell populations in the human early pregnancy decidua: natural killer activity and response to interleukin-2 of CD56-positive large granular lymphocytes.
    Ferry BL; Starkey PM; Sargent IL; Watt GM; Jackson M; Redman CW
    Immunology; 1990 Aug; 70(4):446-52. PubMed ID: 1697563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
    Fujimiya Y; Suzuki Y; Katakura R; Miyagi T; Yamaguchi T; Yoshimoto T; Ebina T
    Clin Cancer Res; 1997 Apr; 3(4):633-43. PubMed ID: 9815731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of adhesion molecules by human decidual large granular lymphocytes.
    Burrows TD; King A; Loke YW
    Cell Immunol; 1993 Mar; 147(1):81-94. PubMed ID: 7681732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promotion of natural killer cell growth in vitro by bispecific (anti-CD3 x anti-CD16) antibodies.
    Malygin AM; Somersalo K; Timonen T
    Immunology; 1994 Jan; 81(1):92-5. PubMed ID: 7510664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphokine-activated killing by human intestinal lymphocytes.
    Ebert EC; Roberts AI
    Cell Immunol; 1993 Jan; 146(1):107-16. PubMed ID: 7678783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals.
    Robertson MJ; Cameron C; Lazo S; Cochran KJ; Voss SD; Ritz J
    Nat Immun; 1996-1997; 15(5):213-26. PubMed ID: 9390270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and immunological effects of granulocyte-macrophage colony-stimulating factor coadministered with interleukin 2: a phase IB study.
    Schiller JH; Hank JA; Khorsand M; Storer B; Borchert A; Huseby-Moore K; Burns D; Wesly O; Albertini MR; Wilding G; Sondel PM
    Clin Cancer Res; 1996 Feb; 2(2):319-30. PubMed ID: 9816175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells.
    Gong JH; Maki G; Klingemann HG
    Leukemia; 1994 Apr; 8(4):652-8. PubMed ID: 8152260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of interleukin 2 and transforming growth factor-beta 2 (TGF-beta 2) on the proliferation and natural killer activity of decidual CD16- CD56bright natural killer cells.
    Saito S; Morii T; Enomoto M; Sakakura S; Nishikawa K; Narita N; Ichijo M
    Cell Immunol; 1993 Dec; 152(2):605-13. PubMed ID: 7504983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effect of IL-2 and IL-6 on the lytic activity of purified human peripheral blood large granular lymphocytes.
    Smyth MJ; Ortaldo JR
    J Immunol; 1991 Feb; 146(4):1380-4. PubMed ID: 1991975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns.
    Doherty DG; Norris S; Madrigal-Estebas L; McEntee G; Traynor O; Hegarty JE; O'Farrelly C
    J Immunol; 1999 Aug; 163(4):2314-21. PubMed ID: 10438977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genesis of human oncolytic natural killer cells from primitive CD34+CD33- bone marrow progenitors.
    Lotzová E; Savary CA; Champlin RE
    J Immunol; 1993 Jun; 150(12):5263-9. PubMed ID: 7685792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.